Medinice is counting on five sales of completed projects - interview

May 29, 2024

We plan to base our medium-term financial strategy on EU and national grants, as well as on revenue from the commercialization of two devices currently in the clinical trial phase. In this strategy, 'commercialization' refers to the sale of fully completed projects — that is, those that have obtained certification allowing the device to be distributed to hospitals. To obtain certification, we strictly adhere to rigorous standards and regulations. As a result, the devices we develop are ready for mass production and meet the highest safety and efficacy standards. The funds obtained from commercialization will be allocated to the development of currently ongoing projects and to paying out at least 50% of the profit as dividends to shareholders. We are counting on at least five such transactions in the coming years, with the first expected by the end of this year,” said Sanjeev Choudhary, Medinice's CEO.